The development and deterioration of pathophysiological processes such inflammation, fibrosis, and oxidative stress in myocardial infarction, hypertension, and hypertrophic cardiomyopathy have been demonstrated to be inhibited by ACE2 [22–24]. The gene discussed is ACE2; the disease is hypertensive disorder.